fda warning bpc 157 compounded peptide not approved FDA's Overreach on Peptides An FDA panel will consider

People receiving high-dose B12 therapy appear more likely to experience skin changes than those taking standard dietary supplements, based on case reports

In type 2 diabetes with chronic kidney disease, semaglutide slowed the progression of kidney damage by about 24%

To prevent exposure incidents, Healthcare providers should wear protective gear such as gloves and gowns while preparing and giving the medication

[1] A review of literature shows that the prevalence of PA is higher in Northern Europe, especially in Scandinavian countries, and among people of African descent, and that increased awareness of the disease and better diagnostic tools might play a role in apparently higher rates of incidence